RusnanoMedInvest and Domain Associates to invest $93m in development of three next-generation pharmaceuticals

  • 20 December 2012

    Russia fund in consortium to back U.S. pharma firms

    Russia fund in consortium to back U.S. pharma firms

    Megan Davies, Reuters

    Russian state technology firm Rusnano, alongside a group of investors, is investing $93 million in three U.S.-based pharmaceutical firms to develop drugs to treat illnesses such as epilepsy, the investors said on Wednesday.

All Portfolio

MEDIA CENTER